JPY 499.0
(1.42%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.16 Billion | 561.86 Million | -218.22 Million | 46.59 Million | 416.77 Million | 145.97 Million |
Net Income | 74.14 Million | 135.73 Million | -1.8 Billion | 279.46 Million | 141.83 Million | 99.73 Million |
Depreciation & Amortization | 358.31 Million | 334.03 Million | 37.39 Million | 32.93 Million | 27.98 Million | 32.67 Million |
Deferred income taxes | - | -61.91 Million | - | - | - | - |
Stock-based compensation | - | 3.91 Million | 2.81 Million | - | - | - |
Change in working capital | 589.68 Million | 127.21 Million | -40.38 Million | 14.14 Million | -12.86 Million | -19.79 Million |
Other non-cash items | 141.85 Million | 22.88 Million | 1.58 Billion | -279.94 Million | 259.81 Million | 33.35 Million |
Investing Cash Flow | -19.76 Million | -87.63 Million | -194.09 Million | -2.51 Billion | -42.8 Million | -63.21 Million |
Investments in PPE | -7.83 Million | -130.92 Million | -189.34 Million | -179.22 Million | -48.46 Million | -55.47 Million |
Acquisitions | - | 4.9 Million | - | -2.33 Billion | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | 158.01 Million | - | - | - | 1.61 Million | - |
Other Investing Activities | -3.7 Million | 38.38 Million | -4.74 Million | 1.7 Million | 4.03 Million | -7.74 Million |
Financing Cash Flow | 121.06 Million | -80.72 Million | -96.72 Million | 2.32 Billion | 74.25 Million | -42.97 Million |
Debt repayment | -84.46 Million | -1.62 Billion | -200 Million | -1.68 Billion | -25.74 Million | -27.97 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -230 Thousand | -131 Thousand | -8000.00 | - | - | - |
Common Stock Issuance | 36.83 Million | 613.33 Million | 53.67 Million | 660.32 Million | - | - |
Other Financing Activities | -2000.00 | 1.86 Billion | 49.61 Million | 3.34 Billion | 100 Million | -15 Million |
Accounts receivables | 185.99 Million | -255.92 Million | -9.92 Million | -1.36 Million | -16.59 Million | -27.65 Million |
Accounts payables | -384.17 Million | 212.65 Million | -18.39 Million | 30.67 Million | -8.76 Million | 6.36 Million |
Inventory | 3.44 Million | 61.59 Million | 20 Thousand | 678 Thousand | 3.87 Million | -4.33 Million |
Other working capital | 784.41 Million | 108.89 Million | -12.09 Million | -15.84 Million | 8.61 Million | 5.82 Million |
Cash at beginning of period | 1.49 Billion | 1.09 Billion | 560.69 Million | 700.34 Million | 252.13 Million | 212.34 Million |
Cash at end of period | 3.22 Billion | 1.49 Billion | 1.09 Billion | 560.69 Million | 700.34 Million | 252.13 Million |
Capital Expenditure | -7.83 Million | -130.92 Million | -189.34 Million | -179.22 Million | -48.46 Million | -55.47 Million |
Effect of forex changes on cash | - | 3.11 Million | 1.04 Billion | 1000.00 | - | - |
Net cash flow / Change in cash | 1.73 Billion | 396.61 Million | 533.63 Million | -139.65 Million | 448.21 Million | 39.78 Million |
Free Cash Flow | 1.15 Billion | 430.93 Million | -407.56 Million | -132.63 Million | 368.3 Million | 90.5 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 152 Million | -13 Million | -1 Million | 42 Million | 135.73 Million | 40 Million |
Depreciation & Amortization | - | - | 69 Million | 68.78 Million | 334.03 Million | 71.26 Million |
Deferred income taxes | - | - | - | - | -61.91 Million | - |
Stock-based compensation | - | - | - | - | 3.91 Million | - |
Change in working capital | - | - | - | - | 127.21 Million | - |
Other non-cash items | -152 Million | 13 Million | 1 Million | -42 Million | 22.88 Million | -40 Million |
Investing Cash Flow | - | - | - | - | -87.63 Million | - |
Investments in PPE | - | - | - | - | -130.92 Million | - |
Acquisitions | - | - | - | - | 4.9 Million | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | 38.38 Million | - |
Financing Cash Flow | - | - | - | - | -80.72 Million | - |
Debt repayment | - | - | - | - | -1.62 Billion | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -131 Thousand | - |
Common Stock Issuance | - | - | - | - | 613.33 Million | - |
Other Financing Activities | - | - | - | - | 1.86 Billion | - |
Accounts receivables | - | - | - | - | -255.92 Million | - |
Accounts payables | - | - | - | - | 212.65 Million | - |
Inventory | - | - | - | - | 61.59 Million | - |
Other working capital | - | - | - | - | 108.89 Million | - |
Cash at beginning of period | - | - | 1.49 Billion | 1.82 Billion | 1.09 Billion | 1.18 Billion |
Cash at end of period | - | - | 1.99 Billion | 1.49 Billion | 1.49 Billion | 1.82 Billion |
Capital Expenditure | - | - | - | - | -130.92 Million | - |
Effect of forex changes on cash | - | - | - | - | 3.11 Million | - |
Net cash flow / Change in cash | - | - | 502.23 Million | -338.14 Million | 396.61 Million | 640.33 Million |
Free Cash Flow | - | - | 138 Million | 137.57 Million | 430.93 Million | 142.52 Million |
NGLFINE
THEMISMED
8929
SDON
MTA
BEML